The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis
Abstract
The effects of the indolehallucinogen psilocybin, a mixed 5-HT2 and 5-HT1 agonist, on regional cerebral glucose metabolism were investigated in 10 healthy volunteers with PET and [F-18]-fluorodeoxyglucose (FDG) prior to and following a 15- or 20-mg dose of psilocybin. Psychotomimetic doses of psilocybin were found to produce a global increase in cerebral metabolic rate of glucose (CMRglu) with significant and most marked increases in the frontomedial and frontolateral cortex (24.3%), anterior cingulate (24.9%), and temporomedial cortex (25.3%). Somewhat smaller increases of CMRglu were found in the basal ganglia (18.5%), and the smallest increases were found in the sensorimotor (14.7%) and occipital cortex (14.4%). The increases of CMRglu in the prefrontal cortex, anterior cingulate, temporomedial cortex, and putamen correlated positively with psychotic symptom formation, in particular with hallucinatory ego disintegration. The present data suggest that excessive 5-HT2 receptor activation results in a hyperfrontal metablic pattern that parallels comparable metabolic findings associated with acute psychotic episodes in chronic schizophrenics and contrasts with the hypofrontality in chronic schizophrenic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Next-generation, psychoplastogenic antidepressants also modulate PFC function with both ketamine and psychedelics increasing PFC activation as measured by 18F-FDG PET imaging (113–116).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [115]
In the citing paper
“Results in a mixed gender group of (n = 10) healthy volunteers indicated a global increase in CMRglc after treatment, which was most distinct (+25%) in the frontal cortex, anterior cingulate and medial temporal cortex, with lesser increases (+15%) in the basal ganglia and sensorimotor and occipital cortical regions.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [137]
In the citing paper
“Whereas Vollenweider et al. [137] reported symmetrical changes in CMRglc, Gouzoulis-Mayfrank et al. [138] saw greater effects in the right hemisphere.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [137]
In the citing paper
“This increased right side perfusion after Ayahuasca [141] and the right side hypermetabolism after psilocybin [137] seem at odds with the right side hypoperfusion after mescaline [140].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [137]
In the citing paper
“The increases in CMRglc were bilateral and roughly symmetrical, but with a tendency for more pronounced increases in the right hemisphere.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [137]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
The attention system of the human brain
Posner, M. I., & Petersen, S. E. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.000325 · Cited by 8,070
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Positron emission tomographic studies of the cortical anatomy of single-word processing
Petersen, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1988) · Nature · doi:10.1038/331585a0 · Cited by 2,593
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Fuster, J. M. (1997) · Cited by 2,244
Dissociation of Object and Spatial Processing Domains in Primate Prefrontal Cortex
Wilson, F. A. W., Scalaidhe, S. P. Ó., & Goldman-Rakic, P. S. (1993) · Science · doi:10.1126/science.8316836 · Cited by 1,410
Patterns of Cerebral Blood Flow in Schizophrenia
Liddle, P. F., Friston, K. J., Frith, C. D., Hirsch, S. R., Jones, T., & Frackowiak, R. S. J. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.179 · Cited by 900
Petrides, M., Alivisatos, B., Meyer, E., & Evans, A. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.878 · Cited by 898
NMDA Antagonist Neurotoxicity: Mechanism and Prevention
Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., & Sesma, M. A. (1991) · Science · doi:10.1126/science.1835799 · Cited by 841
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
“Ettrup et al. (2010) evaluated [11C]CIMBI-5 [N-(2methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine] (25I-NBOMe) as an agonist radioligand for PET imaging of 5-HT2A receptors.”
BackgroundResultInfluentialMeditation states and traits: EEG, ERP, and neuroimaging studies.
Cahn, B. R., & Polich, J. (2006) · Psychological Bulletin · doi:10.1037/0033-2909.132.2.180 · Cited by 1,734
“…and depersonalization phenomena (Farrer et al., 2003; Farrer & Frith, 2002; Kircher & David, 2003; MacDonald & Paus, 2003; Mathew et al., 1999; Sierra, Lopera, Lambert, Phillips, & David, 2002; Simeon et al., 2000; Vollenweider, 1998; Vollenweider & Geyer, 2001; Vollenweider et al., 1997).”
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
“These changes were correlated with measures of psychological state and consistent with potential neurobiological substrates of major mental illnesses.(20) In one recent study, 36 healthy volunteers received a high dose (30 mg/70 kg) of psilocybin with no sustained deleterious physiological or psychological effects.”
ResultHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
“findings that have supported hallucinogens as a model of at least certain aspects of acute psychosis (Gouzoulis-Mayfrank, Heekeren et al., 1998; Vollenweider et al., 1997; Vollenweider and Geyer, 2001; Gouzoulis-Mayfrank et al., 2005, 2006).”
Background
Metadata
- Authors
- Vollenweider, F.
- Affiliations
- University Hospital Zurich (CH)
- Corresponding author
- Vollenweider, F
- ORCID
- Vollenweider, F
- Venue
- Neuropsychopharmacology
- Published
- 1997-05
- Volume
- 16
- Issue
- 5
- Pages
- 357-372
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2048509938
- Cited by
- 444
- References
- 103
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 27 · 2023: 40 · 2022: 35 · 2021: 22 · 2020: 25 · 2019: 9 · 2018: 16 · 2017: 21 · 2016: 30 · 2015: 18 · 2014: 18 · 2013: 10 · 2012: 11
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- University of Bern
- National Research Foundation
- Paul Scherrer Institut
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Keywords
- psilocybin, psychosis, brain glucose metabolism, 5-HT1 receptors, prefrontal cortex, anterior cingulate cortex, putamen, psychotomimetic effects, schizophrenia, hypofrontality
- MeSH terms
- Adult, Animals, Basal Ganglia, Brain, Deoxyglucose, Female, Fluorine Radioisotopes, Frontal Lobe, Hallucinogens, Humans, Male, Psilocybin, Psychological Tests, Psychoses, Substance-Induced, Radioactive Tracers, Tomography, Emission-Computed, Serotonin Receptor Agonists, Fluorodeoxyglucose F18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis. https://app.cochat.ai/papers/10.1016/s0893-133x(96)00246-1
- The paper
- Vollenweider, F. (1997). Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(96)00246-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.